Michael D. Alpert

3.8k total citations
8 papers, 307 citations indexed

About

Michael D. Alpert is a scholar working on Immunology, Infectious Diseases and Virology. According to data from OpenAlex, Michael D. Alpert has authored 8 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Infectious Diseases and 3 papers in Virology. Recurrent topics in Michael D. Alpert's work include HIV Research and Treatment (3 papers), Immune Cell Function and Interaction (3 papers) and T-cell and B-cell Immunology (3 papers). Michael D. Alpert is often cited by papers focused on HIV Research and Treatment (3 papers), Immune Cell Function and Interaction (3 papers) and T-cell and B-cell Immunology (3 papers). Michael D. Alpert collaborates with scholars based in United States and Sweden. Michael D. Alpert's co-authors include David T. Evans, Jackson D. Harvey, Thomas C. Greenough, Maria Allhorn, David E. Williams, Wenjun Li, Ronald C. Desrosiers, Keith G. Mansfield, Angela Carville and R. Keith Reeves and has published in prestigious journals such as American Journal of Psychiatry, Journal of Virology and PLoS Pathogens.

In The Last Decade

Michael D. Alpert

6 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael D. Alpert United States 6 205 201 87 68 50 8 307
Maryse Peressin France 9 242 1.2× 251 1.2× 93 1.1× 58 0.9× 44 0.9× 11 341
Ruimin Pan United States 9 228 1.1× 168 0.8× 99 1.1× 87 1.3× 108 2.2× 15 328
Dariusz K. Murakowski United States 4 185 0.9× 150 0.7× 66 0.8× 154 2.3× 51 1.0× 4 321
Faye Yu United States 7 180 0.9× 158 0.8× 44 0.5× 76 1.1× 126 2.5× 10 325
Marine Malbec France 6 312 1.5× 252 1.3× 75 0.9× 98 1.4× 54 1.1× 7 384
Anna F. Licht United States 7 209 1.0× 259 1.3× 183 2.1× 70 1.0× 63 1.3× 9 377
Jolene A. Glenn United States 9 236 1.2× 239 1.2× 94 1.1× 51 0.8× 125 2.5× 11 355
Michael Vaine United States 10 161 0.8× 149 0.7× 42 0.5× 106 1.6× 118 2.4× 14 322
Skye Spencer United States 3 176 0.9× 149 0.7× 70 0.8× 59 0.9× 119 2.4× 5 273
Trebor Lawton United States 5 236 1.2× 300 1.5× 56 0.6× 97 1.4× 106 2.1× 8 458

Countries citing papers authored by Michael D. Alpert

Since Specialization
Citations

This map shows the geographic impact of Michael D. Alpert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Alpert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Alpert more than expected).

Fields of papers citing papers by Michael D. Alpert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Alpert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Alpert. The network helps show where Michael D. Alpert may publish in the future.

Co-authorship network of co-authors of Michael D. Alpert

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Alpert. A scholar is included among the top collaborators of Michael D. Alpert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Alpert. Michael D. Alpert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Alpert, Michael D., et al.. (2025). Inner-Directed Therapy in MDMA-Assisted Psychotherapy. American Journal of Psychiatry. 183(3). 180–182.
2.
Hopkins, Loren, Sebastian Fuchs, José M. Martinez-Navío, et al.. (2024). In vivo evolution of env in SHIV-AD8EO-infected rhesus macaques after AAV-vectored delivery of eCD4-Ig. Molecular Therapy. 33(2). 560–579.
3.
Mou, Huihui, Brian D. Quinlan, Haiyong Peng, et al.. (2021). Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2. PLoS Pathogens. 17(4). e1009501–e1009501. 34 indexed citations
4.
Jackson, Cody B., Audrey S. Richard, Amrita Ojha, et al.. (2020). AAV vectors engineered to target insulin receptor greatly enhance intramuscular gene delivery. Molecular Therapy — Methods & Clinical Development. 19. 496–506. 14 indexed citations
5.
Alpert, Michael D., Jackson D. Harvey, William A. Lauer, et al.. (2012). ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIVmac251 Challenge. PLoS Pathogens. 8(8). e1002890–e1002890. 118 indexed citations
6.
Alpert, Michael D., David E. Williams, Jackson D. Harvey, et al.. (2012). A Novel Assay for Antibody-Dependent Cell-Mediated Cytotoxicity against HIV-1- or SIV-Infected Cells Reveals Incomplete Overlap with Antibodies Measured by Neutralization and Binding Assays. Journal of Virology. 86(22). 12039–12052. 77 indexed citations
7.
Moldt, Brian, D. Cameron Dunlop, Michael D. Alpert, et al.. (2011). A Panel of IgG1 b12 Variants with Selectively Diminished or Enhanced Affinity for Fcγ Receptors To Define the Role of Effector Functions in Protection against HIV. Journal of Virology. 85(20). 10572–10581. 55 indexed citations
8.
Alpert, Michael D., Andrew R. Rahmberg, William J. Neidermyer, et al.. (2010). Envelope-Modified Single-Cycle Simian Immunodeficiency Virus Selectively Enhances Antibody Responses and Partially Protects against Repeated, Low-Dose Vaginal Challenge. Journal of Virology. 84(20). 10748–10764. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maryse Peressin Breakdown of academic impact, for papers by Ruimin Pan Breakdown of academic impact, for papers by Dariusz K. Murakowski Breakdown of academic impact, for papers by Faye Yu Breakdown of academic impact, for papers by Marine Malbec Breakdown of academic impact, for papers by Anna F. Licht Breakdown of academic impact, for papers by Jolene A. Glenn Breakdown of academic impact, for papers by Michael Vaine Breakdown of academic impact, for papers by Skye Spencer Breakdown of academic impact, for papers by Trebor Lawton
Rankless by CCL
2026